The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Ventricular Dysfunction, Left

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ventricular Dysfunction, Left


High impact information on Ventricular Dysfunction, Left


Chemical compound and disease context of Ventricular Dysfunction, Left


Biological context of Ventricular Dysfunction, Left


Anatomical context of Ventricular Dysfunction, Left


Gene context of Ventricular Dysfunction, Left


Analytical, diagnostic and therapeutic context of Ventricular Dysfunction, Left


  1. Trandolapril in patients with left ventricular dysfunction after myocardial infarction. Neumayr, G., Gänzer, J. N. Engl. J. Med. (1996) [Pubmed]
  2. Dobutamine therapy in acute myocardial infarction. Keung, E.C., Siskind, S.J., Sonneblick, E.H., Ribner, H.S., Schwartz, W.J., LeJemtel, T.H. JAMA (1981) [Pubmed]
  3. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial. de Feyter, P.J., Serruys, P.W., Suryapranata, H. Circulation (1990) [Pubmed]
  4. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Brilla, C.G., Janicki, J.S., Weber, K.T. Circulation (1991) [Pubmed]
  5. Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Dunn, R.F., Uren, R.F., Sadick, N., Bautovich, G., McLaughlin, A., Hiroe, M., Kelly, D.T. Circulation (1982) [Pubmed]
  6. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. Exner, D.V., Dries, D.L., Domanski, M.J., Cohn, J.N. N. Engl. J. Med. (2001) [Pubmed]
  7. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G. N. Engl. J. Med. (2000) [Pubmed]
  8. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. Scognamiglio, R., Rahimtoola, S.H., Fasoli, G., Nistri, S., Dalla Volta, S. N. Engl. J. Med. (1994) [Pubmed]
  9. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. Drazner, M.H., Rame, J.E., Stevenson, L.W., Dries, D.L. N. Engl. J. Med. (2001) [Pubmed]
  10. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. Gill, J.B., Ruddy, T.D., Newell, J.B., Finkelstein, D.M., Strauss, H.W., Boucher, C.A. N. Engl. J. Med. (1987) [Pubmed]
  11. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. Pfeffer, M.A., Braunwald, E., Moyé, L.A., Basta, L., Brown, E.J., Cuddy, T.E., Davis, B.R., Geltman, E.M., Goldman, S., Flaker, G.C. N. Engl. J. Med. (1992) [Pubmed]
  12. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. Packer, M., Carver, J.R., Rodeheffer, R.J., Ivanhoe, R.J., DiBianco, R., Zeldis, S.M., Hendrix, G.H., Bommer, W.J., Elkayam, U., Kukin, M.L. N. Engl. J. Med. (1991) [Pubmed]
  13. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. Rouleau, J.L., Packer, M., Moyé, L., de Champlain, J., Bichet, D., Klein, M., Rouleau, J.R., Sussex, B., Arnold, J.M., Sestier, F. J. Am. Coll. Cardiol. (1994) [Pubmed]
  14. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Pasquet, A., Lauer, M.S., Williams, M.J., Secknus, M.A., Lytle, B., Marwick, T.H. Eur. Heart J. (2000) [Pubmed]
  15. Nisoldipine in severe ischaemic left ventricular dysfunction. Pouleur, H., Rousseau, M.F. Eur. Heart J. (1993) [Pubmed]
  16. Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction. Motwani, J.G., Fenwick, M.K., Struthers, A.D. Eur. Heart J. (1992) [Pubmed]
  17. Comparative haemodynamic effects of intravenous flecainide in patients with and without heart failure and with and without beta-blocker therapy. Legrand, V., Materne, P., Vandormael, M., Collignon, P., Kulbertus, H.E. Eur. Heart J. (1985) [Pubmed]
  18. Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction. Hindman, M.C., Slosky, D.A., Peter, R.H., Newman, G.E., Jones, R.H., Wallace, A.G. Circulation (1980) [Pubmed]
  19. "Hibernating" myocardium: asleep or part dead? Armstrong, W.F. J. Am. Coll. Cardiol. (1996) [Pubmed]
  20. Differential effects of protamine sulfate on myocyte contractile function with left ventricular failure. Hird, R.B., Crawford, F.A., Spinale, F.G. J. Am. Coll. Cardiol. (1995) [Pubmed]
  21. Pulmonary endothelinergic system in experimental congestive heart failure. Lepailleur-Enouf, D., Egidy, G., Philippe, M., Louedec, L., Henry, J., Mulder, P., Michel, J. Cardiovasc. Res. (2001) [Pubmed]
  22. Role of basal release of nitric oxide in the presence of acute left ventricular dysfunction: comparative study with normal condition. Yamamoto, K., Masuyama, T., Mano, T., Naito, J., Kondo, H., Nagano, R., Hori, M., Kamada, T. J. Card. Fail. (1996) [Pubmed]
  23. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Yu, X., Burgess, S.C., Ge, H., Wong, K.K., Nassem, R.H., Garry, D.J., Sherry, A.D., Malloy, C.R., Berger, J.P., Li, C. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  24. A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction. Yazaki, Y., Muhlestein, J.B., Carlquist, J.F., Bair, T.L., Horne, B.D., Renlund, D.G., Anderson, J.L. J. Card. Fail. (2004) [Pubmed]
  25. Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Satoh, M., Nakamura, M., Saitoh, H., Satoh, H., Akatsu, T., Iwasaka, J., Masuda, T., Hiramori, K. Clin. Sci. (2002) [Pubmed]
  26. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Nozaki, N., Yamaguchi, S., Shirakabe, M., Nakamura, H., Tomoike, H. Jpn. Circ. J. (1997) [Pubmed]
  27. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Chen, M.M., Ashley, E.A., Deng, D.X., Tsalenko, A., Deng, A., Tabibiazar, R., Ben-Dor, A., Fenster, B., Yang, E., King, J.Y., Fowler, M., Robbins, R., Johnson, F.L., Bruhn, L., McDonagh, T., Dargie, H., Yakhini, Z., Tsao, P.S., Quertermous, T. Circulation (2003) [Pubmed]
  28. The use of imipramine in depressed patients with congestive heart failure. Glassman, A.H., Johnson, L.L., Giardina, E.G., Walsh, B.T., Roose, S.P., Cooper, T.B., Bigger, J.T. JAMA (1983) [Pubmed]
  29. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lerman, A., Gibbons, R.J., Rodeheffer, R.J., Bailey, K.R., McKinley, L.J., Heublein, D.M., Burnett, J.C. Lancet (1993) [Pubmed]
  30. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Gottdiener, J.S., Mathisen, D.J., Borer, J.S., Bonow, R.O., Myers, C.E., Barr, L.H., Schwartz, D.E., Bacharach, S.L., Green, M.V., Rosenberg, S.A. Ann. Intern. Med. (1981) [Pubmed]
  31. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Greenberg, B., Quinones, M.A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., Shelton, B. Circulation (1995) [Pubmed]
WikiGenes - Universities